Can Vitamin D therapy tackle diabetes, cancer?

13 May,2018 11:26 PM IST |  New York  |  IANS

When beta cells -- the cells in the pancreas that produce, store and release the hormone insulin -- become dysfunctional, the body can not make insulin to control blood sugar (glucose) and levels of glucose can rise to dangerous and even fatal levels


Representational Image

Enhanced activation of Vitamin D by protecting beta cells may be a potential new approach for treating diabetes as well as other diseases, including cancer, researchers have suggested.

When beta cells -- the cells in the pancreas that produce, store and release the hormone insulin -- become dysfunctional, the body can not make insulin to control blood sugar (glucose) and levels of glucose can rise to dangerous and even fatal levels.

The researchers found that Vitamin D in cells and mouse models can be beneficial in treating these damaged beta cells.

They also provided new insights about gene regulation that could be applied to developing treatments for other diseases, including cancer.

"We know that diabetes is a disease caused by inflammation. We identified the Vitamin D receptor as an important modulator of both inflammation and beta cell survival," said Ronald Evans, from Salk Institute for Biological Studies in California, US.

Using beta cells created from embryonic stem cells, the team was able to identify a compound -- iBRD9 -- that appeared to enhance the activation of the Vitamin D receptor when it was combined with Vitamin D to improve the survival of beta cells.

In the paper, published in the journal Cell, the team conducted a screening test to look for compounds that improved the survival of beta cells in a dish. They then tested the combination in a mouse model of diabetes and showed that it could bring glucose back to normal levels in the animals.

Combining the new compound with vitamin D allowed certain protective genes to be expressed at much higher levels than they are in diseased cells.

"Activating the vitamin D receptor can trigger the anti-inflammatory function of genes to help cells survive under stressed conditions," explained Michael Downes, from the institute.

The researchers noted that although the new compound did not appear to cause any side effects in the mice, further testing is needed before clinical trials can begin.

Also Read: Researchers Suggest New Therapy For Drug-Resistant Skin Cancer

Catch up on all the latest Crime, National, International and Hatke news here. Also, download the new mid-day Android and iOS apps to get latest updates

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.
"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!
cancer life and style world news
Related Stories